China Universal Asset Management Company’s Aura Biosciences AURA Stock Holding History

China Universal Asset Management Company’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	24,554 +13,285	+118%	+$95K	0.01%	365
2026 Q1	$75.4K	Buy	11,269 +921	+9%	+$5.29K	0.01%	429
2025 Q4	$56.4K	Sell	10,348 -541	-5%	-$3.21K	﹤0.01%	443
2025 Q3	$67.3K	Sell	10,889 -1,564	-13%	-$10.2K	0.01%	414
2025 Q2	$78K	Buy	12,453 +2,434	+24%	+$14.2K	0.01%	384
2025 Q1	$58.7K	Sell	10,019 -573	-5%	-$4.33K	0.01%	402
2024 Q4	$87.1K	Buy	+10,592	New	+$99.7K	0.01%	409

Other funds holding AURA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

TGAM

TBH Global Asset Management Brentwood, Tennessee $546M AUM 26.68% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

nVerses Capital Wellington, Florida $65M AUM

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

China Universal Asset Management Company's AURA Position: Q2 2026 in Review

China Universal Asset Management Company increased its Aura Biosciences (AURA) stake by 118% in Q2 2026, buying an estimated $95K and bringing the position to 24,554 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #365.

China Universal Asset Management Company first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. 34 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

China Universal Asset Management Company held 24,554 shares of Aura Biosciences worth $174K as of Q2 2026.
China Universal Asset Management Company bought 13,285 Aura Biosciences shares in Q2 2026, an estimated $95K.
Aura Biosciences made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #365 holding.
China Universal Asset Management Company first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
34 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.